About Kaye Edmonton Clinic
Clinical Trials at Kaye Edmonton Clinic
During the past decade, Kaye Edmonton Clinic conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 9 clinical trials were completed. i.e. 225%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kaye Edmonton Clinic" #1 sponsor was "Cytokinetics" with 2 trials, followed by "Gilead Sciences" with 2 trials
sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Baxalta now part of Shire"
with 2 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kaye Edmonton Clinic"
#1 collaborator was "Takeda Development Center Americas, Inc." with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Canadian Orthopaedic Foundation" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Proinnovera GmbH" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Kaye Edmonton Clinic
According to Clinical.Site data, the most researched conditions in "Kaye Edmonton Clinic" are
"Amyotrophic Lateral Sclerosis" (3 trials), "Hemophilia A" (3 trials), "Chronic Hepatitis C" (1 trials), "ECG" (1 trials) and "HIV-1-infection" (1 trials). Many other conditions were trialed in "Kaye Edmonton Clinic" in a lesser frequency.
Clinical Trials Intervention Types at Kaye Edmonton Clinic
Most popular intervention types in "Kaye Edmonton Clinic" are "Drug" (12 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Emicizumab" (2 trials), "Acthar" (1 trials), "Adderall XR" (1 trials) and "Apixaban" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kaye Edmonton Clinic
The vast majority of trials in "Kaye Edmonton Clinic" are
15 trials for "All" genders.
Clinical Trials Status at Kaye Edmonton Clinic
Currently, there are NaN active trials in "Kaye Edmonton Clinic".
undefined are not yet recruiting,
3 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Kaye Edmonton Clinic,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Kaye Edmonton Clinic, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".